Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
The New England Journal of Medicine (2016)
  • John C. Byrd, Ohio State University
  • Bonnie Harrington, Ohio State University
  • Susan O'Brien, University of California, Irvine
  • Jeffrey A. Jones, Ohio State University
  • Anna Schuh, University of Oxford
  • Steve Devereux, University of Cambridge
  • Jorge Chaves
  • William G. Wierda, Orlando Regional Medical Center
  • Farrukh T. Awan, Ohio State University
  • Jennifer R. Brown, Harvard University
  • Peter Hillmen, St James's University Hospital
  • Deborah M. Stephens, University of Utah
  • Paolo Ghia, Vita-Salute San Raffaele University
  • Jacqueline C. Barrientos, Hofstra University
  • John M. Pagel, University of Washington
  • Jennifer Woyach, Ohio State University
  • Dave Johnson
  • Jane Huang, Genentech
  • Xiaolin Wang, University of Amsterdam
  • Allard Kaptein, Merck & Co.
  • Brian J. Lannutti, Ohio State University
  • Todd Covey
  • Maria Fardis
  • Jesse McGreivy
  • Ahmed Hamdy, Hamad Medical Corporation
  • Wayne Rothbaum
  • Raquel Izumi
  • Thomas G. Diacovo, Columbia University
  • Amy J. Johnson, Ohio State University
  • Richard R. Furman, Cornell University
Link
Disciplines
Publication Date
January 28, 2016
DOI
10.1056/NEJMoa1509981
Citation Information
John C. Byrd, Bonnie Harrington, Susan O'Brien, Jeffrey A. Jones, et al.. "Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia" The New England Journal of Medicine Vol. 374 Iss. 4 (2016) p. 323 - 332
Available at: http://works.bepress.com/john-pagel/36/